行情

NVTR

NVTR

Nuvectra
NASDAQ

实时行情|Nasdaq Last Sale

1.540
+0.010
+0.65%
盘后: 1.550 +0.01 +0.65% 16:00 09/23 EDT
开盘
1.500
昨收
1.530
最高
1.780
最低
1.500
成交量
72.49万
成交额
--
52周最高
25.17
52周最低
1.300
市值
2,754.34万
市盈率(TTM)
-0.7142
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NVTR 新闻

  • 美联储研究报告称市场对利率降至零的预期上升
  • 新浪美股.1小时前
  • 调查:用户对iPhone11不那么感兴趣 等待明年5G机型
  • 新浪美股.2小时前
  • 女议员沃伦的财富税或"鼓励"富裕夫妇离婚以避税
  • 新浪美股.3小时前
  • 巨头都爱流媒体蛋糕,苹果、奈飞、迪士尼谁是赢家?
  • 新浪财经-自媒体综合.3小时前

更多

所属板块

生物技术和医学研究
-0.69%
制药与医学研究
-0.43%

热门股票

名称
价格
涨跌幅

NVTR 简况

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company's Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company's commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs. Its technology platform also has capabilities under development to support other neurological indications, such as sacral nerve stimulation (SNS) and deep brain stimulation (DBS). In addition, its NeuroNexus Technologies, Inc. (NeuroNexus) subsidiary designs, manufactures and markets neural-interface technologies for the neuroscience clinical research market. Its Virtis is an application of the Company's neurostimulation technology platform and its first product for the SNS market. Its subsidiaries include Algostim, LLC (Algostim) and PelviStim LLC (PelviStim).
展开

Webull提供Nuvectra Corp的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。